Literature DB >> 17072316

Natural selection on human microRNA binding sites inferred from SNP data.

Kevin Chen1, Nikolaus Rajewsky.   

Abstract

A fundamental problem in biology is understanding how natural selection has shaped the evolution of gene regulation. Here we use SNP genotype data and techniques from population genetics to study an entire layer of short, cis-regulatory sites in the human genome. MicroRNAs (miRNAs) are a class of small noncoding RNAs that post-transcriptionally repress mRNA through cis-regulatory sites in 3' UTRs. We show that negative selection in humans is stronger on computationally predicted conserved miRNA binding sites than on other conserved sequence motifs in 3' UTRs, thus providing independent support for the target prediction model and explicitly demonstrating the contribution of miRNAs to darwinian fitness. Our techniques extend to nonconserved miRNA binding sites, and we estimate that 30%-50% of these are functional when the mRNA and miRNA are endogenously coexpressed. As we show that polymorphisms in predicted miRNA binding sites are likely to be deleterious, they are candidates for causal variants of human disease. We believe that our approach can be extended to studying other classes of cis-regulatory sites.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17072316     DOI: 10.1038/ng1910

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  223 in total

1.  Molecular Mechanism for Hypertensive Renal Disease: Differential Regulation of Chromogranin A Expression at 3'-Untranslated Region Polymorphism C+87T by MicroRNA-107.

Authors:  Kuixing Zhang; Saiful A Mir; C Makena Hightower; Jose Pablo Miramontes-Gonzalez; Adam X Maihofer; Yuqing Chen; Sushil K Mahata; Caroline M Nievergelt; Nicholas J Schork; Barry I Freedman; Sucheta M Vaingankar; Daniel T O'Connor
Journal:  J Am Soc Nephrol       Date:  2014-11-12       Impact factor: 10.121

Review 2.  MicroRNA binding-site polymorphisms as potential biomarkers of cancer risk.

Authors:  Rachel C Blitzblau; Joanne B Weidhaas
Journal:  Mol Diagn Ther       Date:  2010-12-01       Impact factor: 4.074

Review 3.  Evolution of microRNA diversity and regulation in animals.

Authors:  Eugene Berezikov
Journal:  Nat Rev Genet       Date:  2011-11-18       Impact factor: 53.242

4.  Conserved microRNA targeting in Drosophila is as widespread in coding regions as in 3'UTRs.

Authors:  Michael Schnall-Levin; Yong Zhao; Norbert Perrimon; Bonnie Berger
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-20       Impact factor: 11.205

5.  MicroRNA polymorphisms: a giant leap towards personalized medicine.

Authors:  Prasun J Mishra
Journal:  Per Med       Date:  2009-03-01       Impact factor: 2.512

Review 6.  microRNAs and EMT in mammary cells and breast cancer.

Authors:  Josephine A Wright; Jennifer K Richer; Gregory J Goodall
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-05-25       Impact factor: 2.673

7.  MicroRNA-142-3p and microRNA-142-5p are downregulated in hepatocellular carcinoma and exhibit synergistic effects on cell motility.

Authors:  Felice Ho-Ching Tsang; Sandy Leung-Kuen Au; Lai Wei; Dorothy Ngo-Yin Fan; Joyce Man-Fong Lee; Carmen Chak-Lui Wong; Irene Oi-Lin Ng; Chun-Ming Wong
Journal:  Front Med       Date:  2015-08-19       Impact factor: 4.592

8.  The effects of a MAP2K5 microRNA target site SNP on risk for anxiety and depressive disorders.

Authors:  Kevin P Jensen; Henry R Kranzler; Murray B Stein; Joel Gelernter
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2014-01-16       Impact factor: 3.568

9.  Genetic variants in the PIWI-piRNA pathway gene DCP1A predict melanoma disease-specific survival.

Authors:  Weikang Zhang; Hongliang Liu; Jieyun Yin; Wenting Wu; Dakai Zhu; Christopher I Amos; Shenying Fang; Jeffrey E Lee; Yi Li; Jiali Han; Qingyi Wei
Journal:  Int J Cancer       Date:  2016-09-14       Impact factor: 7.396

10.  Identification of a functional SNP in the 3'UTR of CXCR2 that is associated with reduced risk of lung cancer.

Authors:  Bríd M Ryan; Ana I Robles; Andrew C McClary; Majda Haznadar; Elise D Bowman; Sharon R Pine; Derek Brown; Mohammed Khan; Kouya Shiraishi; Takashi Kohno; Hirokazu Okayama; Ramakrishna Modali; Jun Yokota; Curtis C Harris
Journal:  Cancer Res       Date:  2014-12-05       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.